These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2478145)

  • 1. Inflammatory and immunomodulatory roles of TGF-beta.
    Wahl SM; McCartney-Francis N; Mergenhagen SE
    Immunol Today; 1989 Aug; 10(8):258-61. PubMed ID: 2478145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factors.
    Roberts AB; Sporn MB
    Cancer Surv; 1985; 4(4):683-705. PubMed ID: 2890434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factors from neoplastic and nonneoplastic tissues.
    Roberts AB; Frolik CA; Anzano MA; Sporn MB
    Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factors beta.
    Hsuan JJ
    Br Med Bull; 1989 Apr; 45(2):425-37. PubMed ID: 2557115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factors and control of neoplastic cell growth.
    Keski-Oja J; Leof EB; Lyons RM; Coffey RJ; Moses HL
    J Cell Biochem; 1987 Feb; 33(2):95-107. PubMed ID: 3553215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
    Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5339-43. PubMed ID: 6975480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
    Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factors induce markers of neoplasia in cultured adult rat bladder.
    Knowles MA; Hicks RM; Dave H; Harvey AE; Roberts AB; Sporn MB
    Carcinogenesis; 1985 Apr; 6(4):595-604. PubMed ID: 3872740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Trematode Parasite Derived Growth Factor Binds and Exerts Influences on Host Immune Functions via Host Cytokine Receptor Complexes.
    Sulaiman AA; Zolnierczyk K; Japa O; Owen JP; Maddison BC; Emes RD; Hodgkinson JE; Gough KC; Flynn RJ
    PLoS Pathog; 2016 Nov; 12(11):e1005991. PubMed ID: 27806135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
    Torre-Amione G; Beauchamp RD; Koeppen H; Park BH; Schreiber H; Moses HL; Rowley DA
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1486-90. PubMed ID: 2137615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factors--an overview.
    Lawrence DA
    Biol Cell; 1985; 53(2):93-8. PubMed ID: 2988678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.
    Schreiber AB; Winkler ME; Derynck R
    Science; 1986 Jun; 232(4755):1250-3. PubMed ID: 2422759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors from a human tumor cell: characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha.
    Dart LL; Smith DM; Meyers CA; Sporn MB; Frolik CA
    Biochemistry; 1985 Oct; 24(21):5925-31. PubMed ID: 3002426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transforming growth factor-beta and a macrophage- deactivating polypeptide from tumor cells. Differences in antigenicity and mechanism of action.
    Tsunawaki S; Sporn M; Nathan C
    J Immunol; 1989 May; 142(10):3462-8. PubMed ID: 2715632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
    Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
    J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.
    Dasch JR; Pace DR; Waegell W; Inenaga D; Ellingsworth L
    J Immunol; 1989 Mar; 142(5):1536-41. PubMed ID: 2537357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
    Wahl SM; Hunt DA; Wong HL; Dougherty S; McCartney-Francis N; Wahl LM; Ellingsworth L; Schmidt JA; Hall G; Roberts AB
    J Immunol; 1988 May; 140(9):3026-32. PubMed ID: 3129508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.